Medicine guide

Bortezomib Actavis

On the Bulgarian pack: Бортезoмиб Актавис 3,5 mg прах за инжекционен разтвор

3,5 mg · powder for solution for injection

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Bortezomib
Made by
Teva B.V.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01XG01

Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byTeva B.V. · Netherlands
Active substanceBortezomib
Used inCancer treatments and immune-system medicines
Strength3,5 mg
Formpowder for solution for injection
Pack sizes1
ClassificationL01XG01 · Cancer treatments and immune-system medicines
Name in the registerБортезoмиб Актавис 3,5 mg прах за инжекционен разтвор
Reg. no.20150270

Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician

Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.